Hospital
LA Paz Regional Hospital INC
LA Paz Regional Hospital INC was paid $8.26M by Medicaid between Jan 2018 and Dec 2024, across 119 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
33Billing provider infoLA PAZ REGIONAL HOSPITAL INC
PARKER, AZ 85344
PARKER, AZ 85344
33aNPI1053684555assigned 02/14/2012
33bProvider typeCritical Access Hospital
28Total paid$8.26M
24GClaims179,394
24DCodes billed119
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Arizona
Rank by total paid#7 of 15
Median peer was paid$6.92M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 33,143 | $1.57M | |
| 2019 | 25,682 | $1.08M | |
| 2020 | 21,090 | $990K | |
| 2021 | 28,359 | $1.34M | |
| 2022 | 26,380 | $1.23M | |
| 2023 | 24,804 | $1.13M | |
| 2024incomplete | 19,936 | $917K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 5,845 | 5,374 | $1.52M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 3,847 | 3,513 | $1.22M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 2,582 | 2,317 | $1.01M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 11% | 5,336 | 4,918 | $901K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 6.6% | 969 | 870 | $542K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 6.4% | 3,686 | 2,962 | $528K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.8% | 1,912 | 1,649 | $480K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.6% | 626 | 523 | $300K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.0% | 5,114 | 4,374 | $247K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.0% | 5,799 | 4,856 | $164K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.8% | 7,584 | 1,762 | $152K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 4,568 | 3,663 | $150K |
107 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 2,761 | $136K |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 4,547 | $112K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.2% | 3,058 | $101K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.2% | 985 | $100K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,852 | $78K |
| G0378 | Hospital observation service, per hour | <1% | 133 | $63K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,580 | $45K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,441 | $41K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 833 | $37K |
| 80053 | Comprehensive metabolic panel | <1% | 9,152 | $30K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,935 | $23K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,361 | $23K |
| 73630 | <1% | 447 | $21K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 58 | $21K |
| 73562 | <1% | 423 | $20K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 13 | $15K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 274 | $15K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 73 | $14K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,111 | $12K |
| Z7502 | <1% | 310 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,017 | $11K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 418 | $10K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 302 | $9K |
| 73620 | <1% | 53 | $8K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 14 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,434 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,495 | $6K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 50 | $5K |
| 97161 | <1% | 124 | $5K | |
| 73610 | <1% | 89 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 60 | $4K |
| 73030 | <1% | 78 | $3K | |
| 72100 | <1% | 13 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 10,170 | $2K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 668 | $2K |
| 80061 | Lipid panel | <1% | 719 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,688 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 18 | $2K |
| 85610 | <1% | 3,421 | $2K | |
| 80320 | <1% | 1,365 | $2K | |
| 72110 | <1% | 15 | $1K | |
| 93017 | <1% | 16 | $1K | |
| 82553 | <1% | 2,865 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 490 | $1K |
| 84484 | <1% | 3,964 | $1K | |
| 11721 | <1% | 42 | $841.92 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,526 | $794.47 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 220 | $768.33 |
| 83690 | <1% | 2,340 | $760.16 | |
| 83735 | <1% | 4,143 | $732.48 | |
| 81003 | <1% | 1,956 | $725.78 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 424 | $630.40 |
| 82550 | <1% | 2,953 | $572.66 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 896 | $569.57 |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,358 | $560.45 |
| 87070 | <1% | 446 | $550.03 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 256 | $460.02 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 706 | $454.57 |
| 87430 | <1% | 816 | $443.15 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 598 | $438.33 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,772 | $421.16 |
| 83880 | <1% | 646 | $375.17 | |
| 83605 | <1% | 1,361 | $360.99 | |
| 85730 | <1% | 2,091 | $326.69 | |
| 99201 | <1% | 14 | $324.82 | |
| 81001 | <1% | 3,741 | $265.92 | |
| J3490 | Unclassified drugs | <1% | 1,757 | $238.84 |
| 97164 | <1% | 12 | $214.58 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,462 | $203.48 |
| 85027 | <1% | 256 | $201.29 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,672 | $201.25 |
| 81025 | <1% | 801 | $196.00 | |
| 96376 | <1% | 108 | $192.38 | |
| 87088 | <1% | 287 | $184.21 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | <1% | 39 | $158.64 |
| 87186 | <1% | 730 | $143.66 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 744 | $119.86 |
| 97010 | <1% | 1,385 | $106.62 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 113 | $101.94 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,281 | $86.42 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 929 | $83.47 |
| 84703 | <1% | 213 | $72.76 | |
| J2704 | Injection, propofol, 10 mg | <1% | 493 | $42.27 |
| 82150 | <1% | 176 | $38.49 | |
| 87040 | <1% | 116 | $28.14 | |
| 82803 | <1% | 89 | $27.88 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 682 | $26.90 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 108 | $25.17 |
| 87420 | <1% | 140 | $11.79 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 34 | $5.01 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 24 | $4.46 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 91 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 15 | $0.00 |
| 85379 | 0% | 38 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 84 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 18 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 42 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 68 | $0.00 |
| 94760 | 0% | 34 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 20 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 18 | $0.00 |
| 80305 | 0% | 48 | $0.00 | |
| 36600 | 0% | 26 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 93 | $0.00 |
| 81002 | 0% | 52 | $0.00 | |
| 90714 | 0% | 13 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGENC, ZAFER (CEO)
| Provider | Location | Paid |
|---|---|---|
| LA Paz Regional Hospital INC | Parker, AZ | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.